Donald H. Marks, M.D. Ph.D.  

Extant Medical Legal Consulting, LLC

SSRI Drugs: Suicide Acts

A sponsored scientific symposium which took place in Philadelphia 2002.

Introduction

The anti-depressant SSRI Medications (Prozac, Paxil, Zoloft) have been on the market for many years. During that time, increasing awareness of Neuropsychiatric and central nervous system toxic effects of SSRI Medications have come to light. These adverse events now include psychosis, seizures, and suicide acts. Pharmaceutical companies, which do not acknowledge causation, continue to market SSRI Medications.

Purpose

The purpose of this scientific conference wa to explore issues in SSRI Medications toxicity, and the associated pharmaceutical research, development and marketing practices. Areas to be discussed include:

- Clinical Research supporting the claims of safety and efficacy

- The nature of depression and of suicide

- Separating neuro-psychiatric effects of underlying disease from those due to adverse events

- Adverse Event Profile of SSRI medications

- FDA/ Regulatory History

- Failure to Test

- Failure to Warn

- Causation

 Speakers

A highly qualified and experienced faculty has been assembled for this landmark conference, including:

 - Clinical Pharmacology - James Thomas O'Donnell, Pharm.D.

- Internal Medicine and Microbiology - Donald H. Marks, MD, PhD

- Neurology - Larry Shields, MD

- Psychiatrist Terry Maltsberger, MD

- Suicidologist Ronald W. Maris, PhD

- Plaintiff Counsel to be announced

- Patient who experienced SSRI AE

Who Attended

Physicians and nurses who treat patients with depression using SSRI Medications and patients who may have experienced adverse events with SSRI Medications, attorneys involved in SSRI Medications litigation, and medical reviewers of SSRI Medications patient charts.

 Topics

 8 AM Intro Remarks

 8:15 AM Clinical Pharmacology of SSRI Medications

Dr. ODonnell

9:00 AM Clinical Development of SSRI Medications

Dr. Marks

9:45 AM Break

10:00 AM Treatment of Depression, with emphasis on SSRI Medications

Dr. Maltsburger

10:45 AM Neuro-psychiatric adverse events of SSRI Medications

Dr. Marks

11:30 AM Depression and suicide, separating natural process from adverse event.

Dr. Maris

12:15 PM Working Lunch with panel discussion and Q&A opportunity

1:15 PM Regulatory History of SSRI Medications

Dr. Marks

2:00 PM AE reports

Dr. O'Donnell and/or Mr. Keith Altman

2:45 PM Legal issues

plaintiff counsel

3:30 PM Break

3:45 PM AE from SSRI Medications a patient perspective

patient

4:10 PM Screening and Identifying Potential Clients

Dr. Marks

4:40 PM The Psychiatric Autopsy and Other Investigative Techniques

Dr. Maris

5:15 PM Panel Discussion and Closing remarks

Each presentation will last less than 45 minutes. Discussion and questions will follow each presentation to the total of 45 minutes.

Course materials: Every attendee will receive a complete copy of all presentation material.

Fee:

The conference registration fee is $975 per attendee, and $915 per additional attendee from the same office of a company or firm. Cancellations more than 30 days in advance will receive a full refund. Cancellations made less than 10 working days from the conference will receive a 50% refund, less than 5 working days, 25% refund. There is no charge for substitutions. Payment must be received more than 5 working days before the conference in order to attend.

Special Needs: Contact the conference organizer.